Victoza receives FDA nod for treating pediatric patients with type 2 diabetes
by Press Release from Outbreak News Today on (#4HCVR)
The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients since metformin was approved for pediatric use in 2000. Victoza has been approved to treat adult ["]
The post Victoza receives FDA nod for treating pediatric patients with type 2 diabetes appeared first on Outbreak News Today.